IgM-functionalized biomimetic nanovaccine for immunological activation and bacterial toxin neutralization
- 11 May 2025
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 383, 113836
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82273487, 82373817)
This publication has 46 references indexed in Scilit:
- Choice of Nanovaccine Delivery Mode Has Profound Impacts on the Intralymph Node Spatiotemporal Distribution and Immunotherapy EfficacyAdvanced Science, 2020
- Antimicrobial Resistance in Bacteria: Mechanisms, Evolution, and PersistenceJournal of Molecular Evolution, 2019
- A review on anti-adhesion therapies of bacterial diseasesInfection, 2018
- A strategy for actualization of active targeting nanomedicine practically functioning in a living bodyBiomaterials, 2017
- In Situ Capture of Bacterial Toxins for Antivirulence VaccinationAdvanced Materials, 2017
- Stem Cells Loaded with Nanoparticles as a Drug Carrier for In Vivo Breast Cancer TherapyAdvanced Materials, 2014
- Self-Assembled Polymersomes Conjugated with Lactoferrin as Novel Drug Carrier for Brain DeliveryPharmaceutical Research, 2011
- Retraction: T‐bet expression by dendritic cells is required for the repolarization of allergic airway inflammationEuropean Journal of Immunology, 2008
- Pore-forming toxinsCellular and Molecular Life Sciences, 2002
- Hemolytic mechanism of cytolysin produced fromLife Sciences, 1993